Amgen Inc.
Get $10 bonus on your first $100 deposit for AMG.DE
Get $10 bonus on your first $100 deposit for AMG.DE
Amgen Inc. (AMG.DE) Stock Competitors & Peer Comparison
See (AMG.DE) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AMG.DE | €300.25 | +0.74% | 161.9B | 24.37 | €12.32 | +2.75% |
| LLY.DE | €799.60 | -2.19% | 755.5B | 40.16 | €19.91 | +0.67% |
| JNJ.DE | €204.10 | -1.61% | 491.6B | 21.58 | €9.46 | +2.18% |
| 4AB.DE | €179.00 | -1.08% | 316.5B | 87.32 | €2.05 | +3.19% |
| 6MK.DE | €103.80 | -0.92% | 256.6B | 16.63 | €6.24 | +2.74% |
| ZEG.DE | €160.70 | +0.59% | 249.2B | 28.49 | €5.64 | +1.69% |
| GIS.DE | €119.68 | -1.22% | 148.5B | 20.63 | €5.80 | +2.29% |
| PFE.DE | €23.03 | -1.52% | 131B | 19.85 | €1.16 | +6.37% |
| PFE.F | €22.92 | -1.99% | 130.3B | 19.76 | €1.16 | +6.41% |
| BRM.DE | €50.00 | -1.22% | 101.8B | 16.89 | €2.96 | +4.29% |
Stock Comparison
AMG.DE vs LLY.DE Comparison April 2026
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 161.9B. In comparison, LLY.DE has a market cap of 755.5B. Regarding current trading prices, AMG.DE is priced at €300.25, while LLY.DE trades at €799.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 24.37, whereas LLY.DE's P/E ratio is 40.16. In terms of profitability, AMG.DE's ROE is +0.97%, compared to LLY.DE's ROE of +0.98%. Regarding short-term risk, AMG.DE is less volatile compared to LLY.DE. This indicates potentially lower risk in terms of short-term price fluctuations for AMG.DE.Check LLY.DE's competition here
AMG.DE vs JNJ.DE Comparison April 2026
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 161.9B. In comparison, JNJ.DE has a market cap of 491.6B. Regarding current trading prices, AMG.DE is priced at €300.25, while JNJ.DE trades at €204.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 24.37, whereas JNJ.DE's P/E ratio is 21.58. In terms of profitability, AMG.DE's ROE is +0.97%, compared to JNJ.DE's ROE of +0.34%. Regarding short-term risk, AMG.DE is less volatile compared to JNJ.DE. This indicates potentially lower risk in terms of short-term price fluctuations for AMG.DE.Check JNJ.DE's competition here
AMG.DE vs 4AB.DE Comparison April 2026
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 161.9B. In comparison, 4AB.DE has a market cap of 316.5B. Regarding current trading prices, AMG.DE is priced at €300.25, while 4AB.DE trades at €179.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 24.37, whereas 4AB.DE's P/E ratio is 87.32. In terms of profitability, AMG.DE's ROE is +0.97%, compared to 4AB.DE's ROE of -3.62%. Regarding short-term risk, AMG.DE is less volatile compared to 4AB.DE. This indicates potentially lower risk in terms of short-term price fluctuations for AMG.DE.Check 4AB.DE's competition here
AMG.DE vs 6MK.DE Comparison April 2026
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 161.9B. In comparison, 6MK.DE has a market cap of 256.6B. Regarding current trading prices, AMG.DE is priced at €300.25, while 6MK.DE trades at €103.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 24.37, whereas 6MK.DE's P/E ratio is 16.63. In terms of profitability, AMG.DE's ROE is +0.97%, compared to 6MK.DE's ROE of +0.36%. Regarding short-term risk, AMG.DE is less volatile compared to 6MK.DE. This indicates potentially lower risk in terms of short-term price fluctuations for AMG.DE.Check 6MK.DE's competition here
AMG.DE vs ZEG.DE Comparison April 2026
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 161.9B. In comparison, ZEG.DE has a market cap of 249.2B. Regarding current trading prices, AMG.DE is priced at €300.25, while ZEG.DE trades at €160.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 24.37, whereas ZEG.DE's P/E ratio is 28.49. In terms of profitability, AMG.DE's ROE is +0.97%, compared to ZEG.DE's ROE of +0.23%. Regarding short-term risk, AMG.DE is less volatile compared to ZEG.DE. This indicates potentially lower risk in terms of short-term price fluctuations for AMG.DE.Check ZEG.DE's competition here
AMG.DE vs GIS.DE Comparison April 2026
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 161.9B. In comparison, GIS.DE has a market cap of 148.5B. Regarding current trading prices, AMG.DE is priced at €300.25, while GIS.DE trades at €119.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 24.37, whereas GIS.DE's P/E ratio is 20.63. In terms of profitability, AMG.DE's ROE is +0.97%, compared to GIS.DE's ROE of +0.41%. Regarding short-term risk, AMG.DE is less volatile compared to GIS.DE. This indicates potentially lower risk in terms of short-term price fluctuations for AMG.DE.Check GIS.DE's competition here
AMG.DE vs PFE.DE Comparison April 2026
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 161.9B. In comparison, PFE.DE has a market cap of 131B. Regarding current trading prices, AMG.DE is priced at €300.25, while PFE.DE trades at €23.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 24.37, whereas PFE.DE's P/E ratio is 19.85. In terms of profitability, AMG.DE's ROE is +0.97%, compared to PFE.DE's ROE of +0.09%. Regarding short-term risk, AMG.DE is less volatile compared to PFE.DE. This indicates potentially lower risk in terms of short-term price fluctuations for AMG.DE.Check PFE.DE's competition here
AMG.DE vs PFE.F Comparison April 2026
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 161.9B. In comparison, PFE.F has a market cap of 130.3B. Regarding current trading prices, AMG.DE is priced at €300.25, while PFE.F trades at €22.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 24.37, whereas PFE.F's P/E ratio is 19.76. In terms of profitability, AMG.DE's ROE is +0.97%, compared to PFE.F's ROE of +0.09%. Regarding short-term risk, AMG.DE is less volatile compared to PFE.F. This indicates potentially lower risk in terms of short-term price fluctuations for AMG.DE.Check PFE.F's competition here
AMG.DE vs BRM.DE Comparison April 2026
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 161.9B. In comparison, BRM.DE has a market cap of 101.8B. Regarding current trading prices, AMG.DE is priced at €300.25, while BRM.DE trades at €50.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 24.37, whereas BRM.DE's P/E ratio is 16.89. In terms of profitability, AMG.DE's ROE is +0.97%, compared to BRM.DE's ROE of +0.39%. Regarding short-term risk, AMG.DE is less volatile compared to BRM.DE. This indicates potentially lower risk in terms of short-term price fluctuations for AMG.DE.Check BRM.DE's competition here
AMG.DE vs SNW.DE Comparison April 2026
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 161.9B. In comparison, SNW.DE has a market cap of 96.5B. Regarding current trading prices, AMG.DE is priced at €300.25, while SNW.DE trades at €80.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 24.37, whereas SNW.DE's P/E ratio is 19.90. In terms of profitability, AMG.DE's ROE is +0.97%, compared to SNW.DE's ROE of +0.15%. Regarding short-term risk, AMG.DE is less volatile compared to SNW.DE. This indicates potentially lower risk in terms of short-term price fluctuations for AMG.DE.Check SNW.DE's competition here
AMG.DE vs BAYN.DE Comparison April 2026
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 161.9B. In comparison, BAYN.DE has a market cap of 39.4B. Regarding current trading prices, AMG.DE is priced at €300.25, while BAYN.DE trades at €40.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 24.37, whereas BAYN.DE's P/E ratio is -10.90. In terms of profitability, AMG.DE's ROE is +0.97%, compared to BAYN.DE's ROE of -0.12%. Regarding short-term risk, AMG.DE is less volatile compared to BAYN.DE. This indicates potentially lower risk in terms of short-term price fluctuations for AMG.DE.Check BAYN.DE's competition here
AMG.DE vs BAYN.SG Comparison April 2026
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 161.9B. In comparison, BAYN.SG has a market cap of 39.4B. Regarding current trading prices, AMG.DE is priced at €300.25, while BAYN.SG trades at €40.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 24.37, whereas BAYN.SG's P/E ratio is N/A. In terms of profitability, AMG.DE's ROE is +0.97%, compared to BAYN.SG's ROE of -0.12%. Regarding short-term risk, AMG.DE is less volatile compared to BAYN.SG. This indicates potentially lower risk in terms of short-term price fluctuations for AMG.DE.Check BAYN.SG's competition here
AMG.DE vs IDP.DE Comparison April 2026
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 161.9B. In comparison, IDP.DE has a market cap of 21.7B. Regarding current trading prices, AMG.DE is priced at €300.25, while IDP.DE trades at €148.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 24.37, whereas IDP.DE's P/E ratio is 19.40. In terms of profitability, AMG.DE's ROE is +0.97%, compared to IDP.DE's ROE of +0.07%. Regarding short-term risk, AMG.DE is less volatile compared to IDP.DE. This indicates potentially lower risk in terms of short-term price fluctuations for AMG.DE.Check IDP.DE's competition here
AMG.DE vs GS7.DE Comparison April 2026
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 161.9B. In comparison, GS7.DE has a market cap of 0. Regarding current trading prices, AMG.DE is priced at €300.25, while GS7.DE trades at €20.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 24.37, whereas GS7.DE's P/E ratio is 17.31. In terms of profitability, AMG.DE's ROE is +0.97%, compared to GS7.DE's ROE of +0.34%. Regarding short-term risk, AMG.DE is less volatile compared to GS7.DE. This indicates potentially lower risk in terms of short-term price fluctuations for AMG.DE.Check GS7.DE's competition here